Curative and palliative endoscopic treatment of esophageal and gastric cancers. Barett's esophagus (BE) follow-up and management
Seance of wednesday 17 april 2024 (Journée de Cancérologie : cancers oeso-gastriques)
DOI number : 10.26299/c71c-wv41/emem.2024.14.02
Abstract
Interventional digestive endoscopy enables cancerous or precancerous lesions of the esophagus and stomach to be treated minimally invasively, i.e. while preserving the integrity and function of the organ.
Resection techniques, such as endoscopic submucosal dissection (ESD), enable extensive tumors to be treated carcinologically. Barett's esophagus is a complication of gastroesophageal reflux disease. It is an example of a pre-cancerous lesion of the esophagus that needs to be monitored and treated endoscopically when dysplasia or superficial adenocarcinoma appears.
Palliative endoscopic management of esophageal and gastric cancer involves restoring digestive continuity in the face of neoplastic stenosis. Placement of an expandable metal stent is the technique of choice to enable oral re-feeding and significantly improve patients' quality of life.
Resection techniques, such as endoscopic submucosal dissection (ESD), enable extensive tumors to be treated carcinologically. Barett's esophagus is a complication of gastroesophageal reflux disease. It is an example of a pre-cancerous lesion of the esophagus that needs to be monitored and treated endoscopically when dysplasia or superficial adenocarcinoma appears.
Palliative endoscopic management of esophageal and gastric cancer involves restoring digestive continuity in the face of neoplastic stenosis. Placement of an expandable metal stent is the technique of choice to enable oral re-feeding and significantly improve patients' quality of life.